
- Volume 0 0
Aciphex
Eisai Inc (Teaneck, NJ) recentlyannounced that it has assumed US distributionresponsibilities for Aciphex(rabeprazole sodium) from JanssenPharmaceutica Inc affiliate JOMPharmaceutical Services. Eisai andJanssen will continue to co-promoteAciphex, a proton pump inhibitor prescribedfor gastro-esophageal reflux disease(GERD). Eisai is fulfilling purchaseorders for Aciphex from a contract distributioncenter in Memphis, Tenn.The productis indicated for the treatment of symptomaticGERD, healing of erosive GERD,and maintenance of healed erosiveGERD. Aciphex also is approved as partof the first 7-day treatment forHelicobacter pylori infections, the singlemost common cause of peptic ulcers. Formore information, visit www.aciphex.com,or call 888-4ACIPHEX (888-422-4743).
Articles in this issue
over 21 years ago
Interface Speeds Up Prescription Fillingover 21 years ago
New Technologies Top Surveyover 21 years ago
Partnership Addresses Packaging Solutionsover 21 years ago
PDX Software Gets High Marksover 21 years ago
Polar Powder Cold Pak with Magnetic Therapyover 21 years ago
Seal•ONover 21 years ago
SaltAire Sinus Reliefover 21 years ago
Zim's Crack Creme Hand Sanitizerover 21 years ago
CoroWise Plant Sterolsover 21 years ago
CulturelleNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.